142 related articles for article (PubMed ID: 11207049)
1. The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications.
Ria F; Landriscina M; Remiddi F; Rosselli R; Iacoangeli M; Scerrati M; Pani G; Borrello S; Galeotti T
Br J Cancer; 2001 Feb; 84(4):529-34. PubMed ID: 11207049
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression of manganese superoxide dismutase is a candidate prognostic marker for glioblastoma.
Park CK; Jung JH; Moon MJ; Kim YY; Kim JH; Park SH; Kim CY; Paek SH; Kim DG; Jung HW; Cho BK
Oncology; 2009; 77(3-4):178-81. PubMed ID: 19641337
[TBL] [Abstract][Full Text] [Related]
3. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
[TBL] [Abstract][Full Text] [Related]
6. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
[TBL] [Abstract][Full Text] [Related]
7. Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis.
Asgari S; Röhrborn HJ; Engelhorn T; Stolke D
Acta Neurochir (Wien); 2003 Jun; 145(6):453-59; discussion 459-60. PubMed ID: 12836069
[TBL] [Abstract][Full Text] [Related]
8. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.
Nozoe T; Honda M; Inutsuka S; Yasuda M; Korenaga D
Oncol Rep; 2003; 10(1):39-43. PubMed ID: 12469142
[TBL] [Abstract][Full Text] [Related]
9. [Glioblastomas: clinical study and search for prognostic factors].
Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
[TBL] [Abstract][Full Text] [Related]
10. Manganese superoxide dismutase expression in human central nervous system tumors.
Cobbs CS; Levi DS; Aldape K; Israel MA
Cancer Res; 1996 Jul; 56(14):3192-5. PubMed ID: 8764104
[TBL] [Abstract][Full Text] [Related]
11. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
[TBL] [Abstract][Full Text] [Related]
12. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
[TBL] [Abstract][Full Text] [Related]
13. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.
Hermann B; Li Y; Ray MB; Wo JM; Martin RC
Arch Surg; 2005 Dec; 140(12):1204-9; discussion 1209. PubMed ID: 16365243
[TBL] [Abstract][Full Text] [Related]
14. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
15. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
16. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
[TBL] [Abstract][Full Text] [Related]
17. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
18. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer.
Janssen AM; Bosman CB; van Duijn W; Oostendorp-van de Ruit MM; Kubben FJ; Griffioen G; Lamers CB; van Krieken JH; van de Velde CJ; Verspaget HW
Clin Cancer Res; 2000 Aug; 6(8):3183-92. PubMed ID: 10955802
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
20. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma.
Hidaka T; Hama S; Shrestha P; Saito T; Kajiwara Y; Yamasaki F; Sugiyama K; Kurisu K
Anticancer Res; 2009 Feb; 29(2):597-603. PubMed ID: 19331209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]